# Binod Dhakal, MD – FDA Inspection, Jun 26, 2026

Source: https://www.keypedia.com/records/fda_inspections/binod-dhakal-md/d7826343-7b1e-42f7-8f2d-112657b6a70a
Source feed: FDA_Inspections

> FDA inspection 1323738 of Binod Dhakal, MD, June 26, 2026. 1 citation under 21 CFR part 312. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1323738
- Company Name: Binod Dhakal, MD
- Inspection Date: 2026-06-26
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Minneapolis District Office
- Citation Count: 1

## Related Documents

- FDA Inspection 1224651 - 2023-11-17

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/victoria-r-flournoy/f8bdf401-7e11-4706-9d36-d8eab4fe46ff)

Company: https://www.keypedia.com/companies/binod-dhakal-md/154cc239-f3d4-4cc1-b370-ef279b062fd2

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d
